News & Events

Nobel Prize 2018 elevates awareness of immunotherapy research

December 10, 2018

Researchers at the Biodesign Institute are searching for new ways to diagnose, treat – and even cure – cancer patients using processes related to immunotherapy. According to the National Cancer Institute, immunotherapy is “a type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.” The burgeoning field of immunotherapy was recently recognized at the highest level with the announcement of the 2018...

Calling all Deadheads: ASU hosts Zombie Apocalypse Medicine Meeting

October 10, 2018

We see it in movies, TV shows and books, but we rarely see it in science – the zombie apocalypse may be nearer than we think, and an ASU-hosted event intends to address that. On Oct. 18-21, ASU will host the Zombie Apocalypse Medicine Meeting, an interdisciplinary gathering blending the arts and sciences to address the provocative, ever-engaging topic of zombies. According to the website, a zombie is defined as “an entity that is fully or partially under control of another entity,” a...

Escape from the lab! Six promising biotech start-up companies profiled at all-day symposium

October 1, 2018

  ASU’s many laboratories are seedbeds for an astonishing variety of new ideas. But the path from basic research to real-world applications can be complex, perilous and sometimes, bewildering. Recently, an all-day seminar, hosted at the Biodesign Institute, explored an array of promising research that has escaped the confines of the lab. New spinout companies, based on pathbreaking research, are bringing exciting innovations in the life sciences to market. The gathering was...

Gemneo Bioscience receives entrepreneurship award from Flinn Foundation

March 1, 2018

Gemneo Bioscience, a genomics technology company seeking to revolutionize diagnosis and treatment for cancer and other diseases, was named last week as one of six Arizona bioscience startup firms that will participate in the Flinn Foundation’s 2018 Bioscience Entrepreneurship Program. Gemneo will receive $30,000 in funding support and program services through a nonprofit partner. Gemneo was selected from 30 applicants, a record for the program. “The six companies chosen this year are...

Graduate from microbiology PhD program launches career in immunology

December 22, 2017

Editor’s note: This is part of a series of profiles for fall 2017 commencement. See more graduates here. Constant discovery and innovation. That’s how Louis Schoettle describes why he chose to study immunology as part of Arizona State University’s microbiology PhD program from the School of Life Sciences, even though when he started his graduate career, he wondered whether he could take on such a difficult field. He also wondered whether working across multiple laboratories to...

World's Fastest Movies Capture Molecules in Motion

May 8, 2017

In the latest issue of Scientific American, ASU researchers Petra Fromme and John Spence take readers on a whirlwind tour of their powerful X-ray science, where “new movies of drug proteins or photosynthesis in action, shot in millionths of a billionth of a second, show how the molecules work—or fail.”   It’s a world where “proteins are in constant motion, carrying out the reactions that make life possible. These movements happen on a scale too small, and too fast, to be seen...

ASU symposium examines cheating

February 21, 2017

The guy at work who contributes squat to a team project. The one who develops alligator arms every time the check arrives. The people you’ve had for dinner 20 times who always show up empty-handed. Does it make you feel any better that ants, bees and wasps suffer from similar company? Arizona State University’s first Cooperation and Conflict Symposium was held Thursday, bringing scholars from around campus and the world to discuss “Solving the problem of cheating in large-scale...

ASU’s 100th spinout company individualizes cancer treatment

February 21, 2017

Gemneo Bioscience, the 100th company to spin out from the ideas of ASU faculty and staff, will provide physicians with more optimal cancer treatments and immunotherapies to help improve cancer outcomes. Currently, cancer patients often undergo a variety of regimens, that can all-too-often fail and further compromise the immune system, as physicians try to identify which treatments will work. The trial-and-error approach can increase painful side effects and take valuable time, which for...

A Flamenco Guitar Performance

September 23, 2015

Joe Blattman, Ph.D., Assistant Professor, Biodesign’s Center for Infectious Diseases and Vaccinology Our very own Joe Blattman will play flamenco guitar music at sunset in a James Turrell Sky Space that is a contemporary interpretation of ancient Hohokam shade ramadas. This is a Spirit of the Senses salon. Members, employees and their guests are welcome. More information  

New research probes key component of the immune system

June 24, 2015

In the immune system, CD8 T cells perform a dual role, guarding against infection and mediating the progression of disease. Like acutely sensitive watchmen, they patrol the bloodstream, ever on-guard for suspicious activity. Such cells are said to be cytotoxic— lethal to their enemies, which include virally or bacterially infected cells as well as cancer cells.  While CD8 T cell activity provides an indispensible line of defense against infection, it can be a double-edged sword. CD8 T...